progesterone capsule
bryant ranch prepack - progesterone (unii: 4g7ds2q64y) (progesterone - unii:4g7ds2q64y) - progesterone 200 mg - progesterone, usp capsules are indicated for use in the prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving conjugated estrogens tablets. they are also indicated for use in secondary amenorrhea. progesterone, usp capsules should not be used in women with any of the following conditions:
medroxyprogesterone acetate injection, suspension
a-s medication solutions - medroxyprogesterone acetate (unii: c2qi4ioi2g) (medroxyprogesterone - unii:hsu1c9yres) - medroxyprogesterone acetate 150 mg in 1 ml - medroxyprogesterone acetate (mpa) injectable suspension, usp is indicated for use by females of reproductive potential to prevent pregnancy. limitations of use : the use of mpa injectable suspension, usp is not recommended as a long-term (i.e., longer than 2 years) birth control method unless other options are considered inadequate [see dosage and administration (2.1) and warnings and precautions (5.1)]. the use of mpa injectable suspension, usp is contraindicated in the following conditions: - known or suspected pregnancy or as a diagnostic test for pregnancy. - active thrombophlebitis, or current or past history of thromboembolic disorders, or cerebral vascular disease [see warnings and precautions (5.2)] . - known or suspected malignancy of breast [see warnings and precautions (5.3)] . - known hypersensitivity to mpa injectable suspension, usp (medroxyprogesterone acetate) or any of its other ingredients [see warnings and precautions (5.5)] . - significant liver disease [see warnings and precautions (5.7)]
endometrin
ferring pharmaceuticals ltd - progesterone - vaginal tablets - progesterone 100 mg - progesterone - progesterone - progesterone supplementation or replacement in cases such as treatment of infertile women and ivf.
progesterone 400 mg pessaries
actavis group ptc ehf - progesterone - pessary - 400 milligram(s) - pregnen (4) derivatives; progesterone
progesterone 400 mg pessaries
l.d. collins & co ltd - progesterone - pessary - 400 milligram(s) - pregnen (4) derivatives; progesterone
hydroxyprogesterone caproate injection
prasco laboratories - hydroxyprogesterone caproate (unii: 276f2o42f5) (hydroxyprogesterone - unii:21807m87j2) - hydroxyprogesterone caproate injection is a progestin indicated to reduce the risk of preterm birth in women with a singleton pregnancy who have a history of singleton spontaneous preterm birth. the effectiveness of hydroxyprogesterone caproate injection is based on improvement in the proportion of women who delivered < 37 weeks of gestation. there are no controlled trials demonstrating a direct clinical benefit, such as improvement in neonatal mortality and morbidity. limitation of use : while there are many risk factors for preterm birth, safety and efficacy of hydroxyprogesterone caproate injection has been demonstrated only in women with a prior spontaneous singleton preterm birth. it is not intended for use in women with multiple gestations or other risk factors for preterm birth. do not use hydroxyprogesterone caproate in women with any of the following conditions: - current or history of thrombosis or thromboembolic disorders - known or suspected breast cancer, other hormone-sensitive cancer,
progesterone 400 mg pessaries
gedeon richter plc - progesterone - pessary - 400 milligram(s) - pregnen (4) derivatives; progesterone
pms-progesterone inj 50mg/ml usp liquid
pharmascience inc - progesterone - liquid - 50mg - progesterone 50mg - progestins
penta-medroxyprogesterone tablets
pentapharm ltd. - medroxyprogesterone acetate - tablet - 2.5mg - medroxyprogesterone acetate 2.5mg - progestins
penta-medroxyprogesterone tablets
pentapharm ltd. - medroxyprogesterone acetate - tablet - 5mg - medroxyprogesterone acetate 5mg - progestins